UY33384A - DRONEDARONA TO PREVENT ACCIDENTS OF HEADPHONES FIBRILATION - Google Patents

DRONEDARONA TO PREVENT ACCIDENTS OF HEADPHONES FIBRILATION

Info

Publication number
UY33384A
UY33384A UY0001033384A UY33384A UY33384A UY 33384 A UY33384 A UY 33384A UY 0001033384 A UY0001033384 A UY 0001033384A UY 33384 A UY33384 A UY 33384A UY 33384 A UY33384 A UY 33384A
Authority
UY
Uruguay
Prior art keywords
dronedarona
fibrilation
headphones
prevent accidents
cardiovascular
Prior art date
Application number
UY0001033384A
Other languages
Spanish (es)
Inventor
Gaudin Christophe
Martin Van Eickels
Original Assignee
Sanofi Adventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10305514A external-priority patent/EP2387996A1/en
Priority claimed from EP10305522A external-priority patent/EP2387997A1/en
Application filed by Sanofi Adventis filed Critical Sanofi Adventis
Publication of UY33384A publication Critical patent/UY33384A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para la prevención de la muerte o las hospitalizaciones cardiovasculares o los sucesos cardiovasculares particularmente el ictus, el síndrome coronario agudo o la muerte cardiovascular en pacientes con fibrilación auricular permanente.Use of dronedarone for the preparation of a drug for the prevention of death or cardiovascular hospitalizations or cardiovascular events, particularly stroke, acute coronary syndrome or cardiovascular death in patients with permanent atrial fibrillation.

UY0001033384A 2010-05-13 2011-05-13 DRONEDARONA TO PREVENT ACCIDENTS OF HEADPHONES FIBRILATION UY33384A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33435010P 2010-05-13 2010-05-13
EP10305514A EP2387996A1 (en) 2010-05-17 2010-05-17 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation
EP10305522A EP2387997A1 (en) 2010-05-18 2010-05-18 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered
US34610210P 2010-05-19 2010-05-19

Publications (1)

Publication Number Publication Date
UY33384A true UY33384A (en) 2011-12-30

Family

ID=44260395

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033384A UY33384A (en) 2010-05-13 2011-05-13 DRONEDARONA TO PREVENT ACCIDENTS OF HEADPHONES FIBRILATION

Country Status (4)

Country Link
AR (1) AR081392A1 (en)
TW (1) TW201200131A (en)
UY (1) UY33384A (en)
WO (1) WO2011141888A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (en) 1990-08-06 1992-11-27 Sanofi Sa AMINO-BENZOFURAN, BENZOTHIOPHENE OR INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING THEM.
JP2011518785A (en) * 2008-04-17 2011-06-30 サノフイ−アベンテイス Use of dronedarone to prepare drugs for the prevention of cardiovascular hospitalization or death
EP2133074A1 (en) * 2008-06-10 2009-12-16 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of permanent atrial fibrillation
EP2153830A1 (en) * 2008-08-07 2010-02-17 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of stroke or transient ischemic attack

Also Published As

Publication number Publication date
TW201200131A (en) 2012-01-01
AR081392A1 (en) 2012-08-29
WO2011141888A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
ECSP10010666A (en) DRONEDARONA FOR THE PREVENTION OF PERMANENT HEADPHONE FIBRILATION
RS54873B1 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX2015008628A (en) Boronic acid derivatives and therapeutic uses thereof.
NI201000172A (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINE FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY.
ES2620754T3 (en) Use of 5-androstane (alkyl) -3,5,6-triol in the preparation of neuroprotective drugs
NI201200191A (en) INDOLIZINE DERIVATIVES, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS
BR112012024432A2 (en) fast dissolving pharmaceutical composition
MX2016008429A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease.
NI201100034A (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTION OF STROKE OR TRANSITORY ISCHEMIC ATTACK.
UY32618A (en) ANTITUMORAL COMBINATION INCLUDING AVE8062 AND SORAFENIB
BR112014025416A2 (en) ANTIMALARIC AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THEM AND USE OF THE SAME.
MX2016007682A (en) Pharmaceutical composition comprising amorphous ivabradine.
CL2010001421A1 (en) Use of dronedarone in the preparation of useful medications for the prevention of persistent atrial fibrillation or flutter.
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
HRP20130082A2 (en) Pharmaceutical composition with sustained release of trimetazidine
AR084169A1 (en) COMBINATION THAT INCLUDES A FAMILY DERIVATIVE OF COMBRETASTATINAS AND CETUXIMAB
UY33384A (en) DRONEDARONA TO PREVENT ACCIDENTS OF HEADPHONES FIBRILATION
IN2014KN02981A (en)
IT1398522B1 (en) NEW FUROSSAN HYDRO-SOLUBLE DERIVATIVES WITH ANTITUMORAL ACTIVITY.
CR20140526A (en) DRONEDARONE FOR USE IN LEISHMANIOSIS, FORMULATIONS AND ASSOCIATIONS FOR USE IN LEISHMANIOSIS
RU2013155770A (en) MEANS FOR CORRECTION OF DISTURBANCES IN PULMONARY TISSUE UNDER CYTOSTATIC EXPOSURE
NI201200183A (en) AN ANTI-TUMOR COMBINATION INCLUDING OMBRABULIN, A TAXANE DERIVATIVE AND A PLATINUM DERIVATIVE
TR201009607U (en) Hiding the screws used to assemble the parts.
BR112012007181A2 (en) use of a compound, composition, and, use of composition.
CU20100260A7 (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200626